Holen Sie sich die Stockscreener-App
15.91
1.73%
-0.28
Vorhandelsmarkt:
15.53
-0.38
-2.39%
Schlusskurs vom Vortag:
$16.19
Offen:
$16.32
24-Stunden-Volumen:
186.50K
Relative Volume:
0.53
Marktkapitalisierung:
$805.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-69.13M
KGV:
-9.882
EPS:
-1.61
Netto-Cashflow:
$-50.91M
1W Leistung:
-0.19%
1M Leistung:
+13.64%
6M Leistung:
-19.36%
1J Leistung:
+21.17%
1-Tages-Spanne:
$15.72
$16.58
1-Wochen-Bereich:
$15.72
$17.27
52-Wochen-Spanne:
$12.34
$29.60
Tyra Biosciences Inc Stock (TYRA) Company Profile
Firmenname
Tyra Biosciences Inc
Sektor
Branche
Telefon
(619) 728-4760
Adresse
2656 STATE STREET, CARLSBAD
Vergleichen Sie TYRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
15.91 | 805.09M | 0 | -69.13M | -50.91M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-07 | Eingeleitet | UBS | Buy |
| 2024-10-18 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-15 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-30 | Eingeleitet | Wedbush | Outperform |
| 2023-02-03 | Eingeleitet | Oppenheimer | Outperform |
| 2022-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-03-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-11-08 | Herabstufung | Jefferies | Buy → Hold |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Tyra Biosciences Inc Aktie (TYRA) Neueste Nachrichten
Tyra Biosciences director Nina Kjellson sells shares worth $409,645 By Investing.com - Investing.com Australia
Tyra Biosciences director Nina Kjellson sells shares worth $409,645 - MSN
Trading (TYRA) With Integrated Risk Controls - Stock Traders Daily
Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 4.1%Time to Sell? - MarketBeat
Barclays PLC Has $884,000 Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences (NASDAQ:TYRA) Trading 7.9% HigherHere's What Happened - MarketBeat
JPMorgan Chase & Co. Has $8.67 Million Stock Holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Tyra Biosciences (NASDAQ:TYRA) Given Buy Rating at HC Wainwright - Defense World
Tyra Biosciences' (TYRA) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
FDA greenlights phase 2 SURF302 trial of TYRA-300 in NMIBC - Urology Times
Tyra Falls on FDA Nod - Baystreet.ca
Tyra Biosciences advances bladder cancer drug trial - Investing.com
Tyra Biosciences advances bladder cancer drug trial By Investing.com - Investing.com South Africa
Tyra Biosciences Secures FDA Clearance for TYRA-300 Phase 2 Bladder Cancer Trial - StockTitan
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $31.00 Average Target Price from Brokerages - Defense World
UBS Group Initiates Coverage on Tyra Biosciences (NASDAQ:TYRA) - Defense World
Long Term Trading Analysis for (TYRA) - Stock Traders Daily
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Coverage Initiated at UBS Group - MarketBeat
UBS backs Tyra Biosciences stock with long-term growth forecast driven by TYRA-300 pipeline - Investing.com Canada
12,647 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Bought by Franklin Resources Inc. - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Stake Lifted by Barclays PLC - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Sees Significant Growth in Short Interest - MarketBeat
(TYRA) Trading Report - Stock Traders Daily
State Street Corp Acquires 16,248 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Head to Head Contrast: Tyra Biosciences (NASDAQ:TYRA) and Checkpoint Therapeutics (NASDAQ:CKPT) - Defense World
Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 4.3%What's Next? - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires New Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Wellington Management Group LLP Sells 26,207 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
The Take On Tyra Biosciences (NASDAQ:TYRA) - Seeking Alpha
(TYRA) Trading Signals - Stock Traders Daily
Tyra Biosciences to Present at Upcoming Investor Conferences - The Eastern Progress Online
The Manufacturers Life Insurance Company Invests $333,000 in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
Charles Schwab Investment Management Inc. Increases Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
We're Not Very Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Rate - Simply Wall St
Frazier Life Sciences Management L.P. Cuts Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat
Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET - Victoria Advocate
Janus Henderson Group PLC Takes Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat
Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference - The Eastern Progress Online
Tyra Biosciences Announces Late-Breaking Oral Presentation on Preliminary Safety and Anti-Tumor Activity of TYRA-300 from SURF301 at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2024) - The Eastern Progress Online
(TYRA) Investment Analysis - Stock Traders Daily
Polar Asset Management Partners Inc. Buys New Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat
Tyra Biosciences to Participate in 2023 Jefferies London Healthc - GuruFocus.com
Head to Head Survey: Tyra Biosciences (NASDAQ:TYRA) & Wellness Center USA (OTCMKTS:WCUI) - Defense World
Walleye Capital LLC Has $2.98 Million Holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat
Sio Capital Management LLC Has $9.42 Million Holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat
How to Take Advantage of moves in (TYRA) - Stock Traders Daily
Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 5%Here's Why - MarketBeat
Short Interest in Tyra Biosciences, Inc. (NASDAQ:TYRA) Drops By 20.0% - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Shares Gap UpWhat's Next? - MarketBeat
RA Capital Management, L.P. Increases Stake in Tyra Biosciences Inc - GuruFocus.com
Finanzdaten der Tyra Biosciences Inc-Aktie (TYRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tyra Biosciences Inc-Aktie (TYRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kjellson Nina S | Director |
Jan 16 '25 |
Sale |
16.29 |
7,779 |
126,697 |
447,857 |
| Kjellson Nina S | Director |
Jan 21 '25 |
Sale |
16.36 |
3,993 |
65,336 |
3,707,420 |
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):